Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Openwater is a medical technology company developing a wearable platform that integrates semiconductor physics, light, and sound to diagnose and treat diseases at the cellular level. Founded by Mary Lou Jepsen, a former executive at Google X and Meta, the company aims to replace large, expensive MRI and CT scanners with affordable, portable devices. Its technology combines high-resolution infrared imaging with precision-tuned ultrasound to visualize and selectively treat conditions such as aggressive cancers, mental health disorders, and strokes. By leveraging consumer electronics manufacturing and an open-source model, Openwater seeks to dramatically reduce the cost and time required for medical device innovation. The company's platform, comprising the Open-LIFU and Open-Motion systems, is currently undergoing clinical validation for indications including glioblastoma, severe depression, and large vessel occlusion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Operation Water.